SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-086198
Filing Date
2023-11-13
Accepted
2023-11-13 16:45:31
Documents
66
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_pasithea.htm   iXBRL 10-Q 632414
2 CERTIFICATION f10q0923ex31-1_pasithea.htm EX-31.1 10812
3 CERTIFICATION f10q0923ex31-2_pasithea.htm EX-31.2 10700
4 CERTIFICATION f10q0923ex32-1_pasithea.htm EX-32.1 4312
5 CERTIFICATION f10q0923ex32-2_pasithea.htm EX-32.2 4429
  Complete submission text file 0001213900-23-086198.txt   4369513

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ktta-20230930.xsd EX-101.SCH 44648
7 XBRL CALCULATION FILE ktta-20230930_cal.xml EX-101.CAL 32914
8 XBRL DEFINITION FILE ktta-20230930_def.xml EX-101.DEF 230505
9 XBRL LABEL FILE ktta-20230930_lab.xml EX-101.LAB 448319
10 XBRL PRESENTATION FILE ktta-20230930_pre.xml EX-101.PRE 240420
60 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_pasithea_htm.xml XML 495790
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40804 | Film No.: 231399619
SIC: 2834 Pharmaceutical Preparations